I agree that this site is using cookies. You can find further informations here.
X
Mouret-Reynier, Marie-Ange
238  results:
Search for persons X
?
1

Neoadjuvant anthracycline-based (5-FEC) or anthracycline-fr..:

Ginzac, Angeline ; Molnar, Ioana ; Durando, Xavier...
Breast Cancer Research and Treatment.  205 (2024)  2 - p. 267-279 , 2024
Link: https://doi.org/10.1007/..
 
?
2

Prognostic stratification ability of the CPS+EG scoring sys..:

Roussot, Nicolas ; Constantin, Guillaume ; Desmoulins, Isabelle...
European Journal of Cancer.  202 (2024)  - p. 114037 , 2024
Link: https://doi.org/10.1016/..
 
?
3

Real-World Impact of Adjuvant Anti-HER2 Treatment on Charac..:

Le Du, Fanny ; Carton, Matthieu ; Bachelot, Thomas...
The Oncologist.  28 (2023)  10 - p. e867-e876 , 2023
Link: https://doi.org/10.1093/..
 
?
4

Updated progression-free survival and final overall surviva..:

Lorusso, Domenica ; Mouret-Reynier, Marie-Ange ; Harter, Philipp...
International Journal of Gynecologic Cancer.  34 (2023)  4 - p. 550-558 , 2023
Link: https://doi.org/10.1136/..
 
?
5

Adjuvant endocrine therapy uptake, toxicity, quality of lif..:

Balazard, Félix ; Bertaut, Aurélie ; Bordet, Élise...
JNCI: Journal of the National Cancer Institute.  115 (2023)  9 - p. 1099-1108 , 2023
Link: https://doi.org/10.1093/..
 
?
6

Clinical outcome of patients with isolated central nervous ..:

Collet, Laetitia ; Eberst, Lauriane ; Ludovic, Gauthier...
Breast Cancer.  30 (2023)  2 - p. 329-341 , 2023
Link: https://doi.org/10.1007/..
 
?
7

Low RNA disruption during neoadjuvant chemotherapy predicts..:

Cazzaniga, Marina Elena ; Ademuyiwa, Foluso ; Petit, Thierry...
JNCI Cancer Spectrum.  8 (2023)  1 - p. , 2023
Link: https://doi.org/10.1093/..
 
?
8

PO143 MODELING AN ANNOUNCEMENT PATHWAY FOR PATIENTS ENTERIN..:

Mouret-Reynier, Marie-Ange ; Dalenc, Florence ; Guiu, Severine.
The Breast.  71 (2023)  - p. S66 , 2023
Link: https://doi.org/10.1016/..
 
?
9

Long-Term Results with Everolimus in Advanced Hormone Recep..:

François-Martin, Hélène ; Lardy-Cléaud, Audrey ; Pistilli, Barbara...
Cancers.  15 (2023)  4 - p. 1191 , 2023
Link: https://doi.org/10.3390/..
 
?
10

Regorafenib or Tamoxifen for platinum-sensitive recurrent o..:

Trédan, Olivier ; Provansal, Magali ; Abdeddaim, Cyril...
Gynecologic Oncology.  164 (2022)  1 - p. 18-26 , 2022
Link: https://doi.org/10.1016/..
 
?
11

Impact of lobular versus ductal histology on overall surviv..:

Dalenc, Florence ; Lusque, Amélie ; De La Motte Rouge, Thibault...
European Journal of Cancer.  164 (2022)  - p. 70-79 , 2022
Link: https://doi.org/10.1016/..
 
?
12

Paclitaxel with or without pazopanib for ovarian cancer rel..:

Joly, Florence ; Fabbro, Michel ; Berton, Dominique...
Gynecologic Oncology.  166 (2022)  3 - p. 389-396 , 2022
Link: https://doi.org/10.1016/..
 
?
13

Efficacy of taxanes rechallenge in first-line treatment of ..:

Vasseur, Antoine ; Carton, Matthieu ; Guiu, Severine...
The Breast.  65 (2022)  - p. 136-144 , 2022
Link: https://doi.org/10.1016/..
 
?
14

Gestion pratique des inhibiteurs de PARP : Un consensus nat..:

Selle, Frédéric ; Boffa, Jean-Jacques ; Etienne, Gabriel...
Bulletin du Cancer.  109 (2022)  12 - p. 1245-1261 , 2022
Link: https://doi.org/10.1016/..
 
?
15

Efficacy of trastuzumab emtansine (T-DM1) and lapatinib aft..:

Moinard-Butot, Fabien ; Saint-Martin, Caroline ; Pflumio, Carole...
The Breast.  63 (2022)  - p. 54-60 , 2022
Link: https://doi.org/10.1016/..
 
1-15